Stan L Block

Summary

Country: USA

Publications

  1. ncbi Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, KY, USA
    Pediatr Infect Dis J 23:834-8. 2004
  2. doi Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children
    Stan L Block
    Kentucky Pediatric and Adult Research Inc, Bardstown, KY 40004, USA
    Pediatr Infect Dis J 31:e92-8. 2012
  3. doi Safety and pharmacokinetics of a single 1500-mg dose of famciclovir in adolescents with recurrent herpes labialis
    Stan L Block
    Department of Pediatrics, University of Kentucky College of Medicine, Louisville, KY, USA
    Pediatr Infect Dis J 30:525-8. 2011
  4. doi Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine
    Stan L Block
    Kentucky Pediatric Adult Research, Inc, Bardstown, KY 40004, USA
    Pediatr Infect Dis J 29:95-101. 2010
  5. ncbi A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, 40004, USA
    Clin Ther 27:786-94. 2005
  6. doi Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, KY 40004, United States
    Vaccine 26:4940-6. 2008
  7. doi Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, KY, USA
    Pediatr Infect Dis J 31:745-51. 2012
  8. doi Timing of the availability and administration of influenza vaccine through the vaccines for children program
    Praful Bhatt
    Kentucky Pediatric Research, Bardstown, KY, USA
    Pediatr Infect Dis J 30:100-6. 2011
  9. ncbi Oral beta-lactams in the treatment of acute otitis media
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, KY, USA
    Diagn Microbiol Infect Dis 57:19S-30S. 2007
  10. doi The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, KY, USA
    Pediatr Infect Dis J 30:203-7. 2011

Detail Information

Publications28

  1. ncbi Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, KY, USA
    Pediatr Infect Dis J 23:834-8. 2004
    ..Short course beta-lactam antibiotic therapy for acute otitis media (AOM) should improve patient adherence, but it has not been evaluated since the heptavalent pneumococcal conjugate vaccine became routinely used in the United States...
  2. doi Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children
    Stan L Block
    Kentucky Pediatric and Adult Research Inc, Bardstown, KY 40004, USA
    Pediatr Infect Dis J 31:e92-8. 2012
    ..The successful vaccination of children 6 to 36 months of age against 2009 A/H1N1 influenza was essential to help reduce the burden of pandemic disease in both the pediatric and adult populations...
  3. doi Safety and pharmacokinetics of a single 1500-mg dose of famciclovir in adolescents with recurrent herpes labialis
    Stan L Block
    Department of Pediatrics, University of Kentucky College of Medicine, Louisville, KY, USA
    Pediatr Infect Dis J 30:525-8. 2011
    ..Mean Cmax, mean AUC0-∞, and clearance for penciclovir were 9.37 μg/mL, 31.8 μg · h/mL, and 38.2 L/h, respectively, and within the range extrapolated from data in adults. Adverse events were generally mild and transient...
  4. doi Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine
    Stan L Block
    Kentucky Pediatric Adult Research, Inc, Bardstown, KY 40004, USA
    Pediatr Infect Dis J 29:95-101. 2010
    ..We describe the safety of the human papillomavirus (HPV)-6/11/16/18 vaccine using updated clinical trial data (median follow-up time of 3.6 years) and summarize up to 3 years of post-licensure surveillance...
  5. ncbi A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, 40004, USA
    Clin Ther 27:786-94. 2005
    ..Short-course therapy for acute otitis media (AOM) improves adherence and may reduce secondary bacterial resistance...
  6. doi Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, KY 40004, United States
    Vaccine 26:4940-6. 2008
    ..Live attenuated influenza vaccine (LAIV) is indicated for influenza prevention in persons 2-49 years of age. This study describes the incidence and duration of vaccine virus shedding and serum immune responses after receipt of LAIV...
  7. doi Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, KY, USA
    Pediatr Infect Dis J 31:745-51. 2012
    ....
  8. doi Timing of the availability and administration of influenza vaccine through the vaccines for children program
    Praful Bhatt
    Kentucky Pediatric Research, Bardstown, KY, USA
    Pediatr Infect Dis J 30:100-6. 2011
    ..To our knowledge, no previous studies have simultaneously evaluated the delivery and administration of privately purchased vaccines and influenza vaccines acquired through the Vaccines for Children (VFC) program...
  9. ncbi Oral beta-lactams in the treatment of acute otitis media
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, KY, USA
    Diagn Microbiol Infect Dis 57:19S-30S. 2007
    ..influenzae and S. pneumoniae...
  10. doi The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, KY, USA
    Pediatr Infect Dis J 30:203-7. 2011
    ..LAIV is approved for eligible children aged ≥ 2 years in the United States and in several other countries...
  11. pmc Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects
    Stan L Block
    Kentucky Pediatric Research, 201 S 5th St, Bardstown, KY 40004 1142, USA
    Antimicrob Agents Chemother 51:4001-8. 2007
    ..The immunogenicities, reactogenicity events, and AEs were comparable for refrigerated CAIV-T and frozen LAIV...
  12. doi A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults
    Stan L Block
    Kentucky Pediatric and Adult Research, 201 South 5th Street, Bardstown, KY 40004 1142, USA
    Vaccine 29:9391-7. 2011
    ..Quadrivalent live attenuated influenza vaccine (Q/LAIV) is an investigational 4-strain formulation of LAIV that contains 2 A strains, A/H1N1 and A/H3N2, and 2 B strains, 1 from each lineage...
  13. doi A prospective observational study of US in-office pediatric influenza vaccination during the 2007 to 2009 influenza seasons: use and factors associated with increased vaccination rates
    Praful Bhatt
    Kentucky Pediatric and Adult Research, Bardstown, KY, USA
    Clin Pediatr (Phila) 49:954-63. 2010
    ..Qualitative analyses suggest that increased first-dose administration and 2-dose compliance rates are associated with smaller office size and a greater duration of vaccine availability, respectively, during both seasons...
  14. doi Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine
    Kristina A Bryant
    Department of Pediatrics, University of Louisville, Louisville, KY 40292, USA
    Pediatrics 125:866-75. 2010
    ..The safety and immunogenicity of PCV7 were compared with those of 13-valent PCV (PCV13), which contains saccharides from serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F conjugated to CRM(197)...
  15. doi Post hoc analysis: early changes in ADHD-RS items predict longer term response to atomoxetine in pediatric patients
    Stan L Block
    Kentucky Pediatric Research, Bardstown, KY, USA
    Clin Pediatr (Phila) 49:768-76. 2010
    ..2% and 77.5%), or by the combination of items 1 and 10 (PPVs: 75.1% and 75.4%; NPVs: 72.2% and 77.5%; training and validation data sets, respectively)...
  16. ncbi Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, KY 40004, USA
    Curr Med Res Opin 22:1839-47. 2006
    ....
  17. ncbi Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media
    Stan L Block
    Kentucky Pediatric Research, Inc, Bardstown, KY, USA
    Pediatr Infect Dis J 23:829-33. 2004
    ....
  18. doi Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, Kentucky 40004 1142, USA
    Clin Ther 31:2140-7. 2009
    ..Although 2 doses of influenza vaccine are recommended for children aged <9 years who have not been previously vaccinated, children may receive only 1 dose because of suboptimal adherence to national influenza vaccination recommendations...
  19. ncbi Comparative tolerability, safety and efficacy of tablet formulations of twice-daily clarithromycin 250 mg versus once-daily extended-release clarithromycin 500 mg in pediatric and adolescent patients
    Stan L Block
    201 South 5th Street, Bardstown, KY 40004, USA
    Clin Pediatr (Phila) 45:641-8. 2006
    ..The overall cure rate exceeded 90% for each treatment group. Discontinuation rates and adverse events were 4.5% and 24.6%, respectively...
  20. ncbi Otitis externa: providing relief while avoiding complications
    Stan L Block
    University of Louisville, Louisville, KY, USA
    J Fam Pract 54:669-76. 2005
  21. ncbi Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, Kentucky, USA
    Pediatrics 119:11-8. 2007
    ..Rotavirus is the leading cause of dehydrating acute gastroenteritis in infants worldwide. Previous studies of a live pentavalent human-bovine reassortant rotavirus vaccine have shown it to be efficacious across a range of potencies...
  22. ncbi Pneumococcal serotypes from acute otitis media in rural Kentucky
    Stan L Block
    Kentucky Pediatric Research, Inc, Bardstown, Luisville, KY, USA
    Pediatr Infect Dis J 21:859-65. 2002
    ..Acute otitis media (AOM) accounts for most infections caused by, but few data are available regarding the incidence of pneumococcal serotypes recovered from children with AOM in the United States...
  23. doi Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing
    Stan L Block
    Kentucky Pediatric Research, Bardstown, Kentucky 40004, USA
    Clin Pediatr (Phila) 48:723-33. 2009
    ..Evening dosing showed greater tolerability with significantly more patients receiving morning atomoxetine reporting at least 1 adverse event than those receiving evening atomoxetine...
  24. ncbi Therapeutic nihilists: lend me your ears, or the witches' cauldron of acute otitis media
    Stan L Block
    Kentucky Pediatric Research, Inc, 201 South 5th Street, Bardstown, KY 40004, USA
    Pediatr Ann 31:784-91; quiz 783, 821-3. 2002
  25. doi Use of MenACWY-CRM in adolescents in the United States
    Steven Black
    Department of Pediatrics, Center for Global Health and Division of Infectious Diseases, Cincinnati Children s Hospital, OH, USA
    J Adolesc Health 52:271-7. 2013
    ..Inc., Whitehouse Station, NJ)...
  26. ncbi Role of influenza vaccine for healthy children in the US
    Stan L Block
    Kentucky Pediatric Research, Bardstown, Kentucky 40004, USA
    Paediatr Drugs 6:199-209. 2004
    ..The practitioner must consider the benefits of FluMist compared with its likely higher vaccine cost and the issues of reimbursement among multiple insurers...
  27. ncbi Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women
    Stan L Block
    Kentucky Pediatric Research, Inc, 201 S 5th St, Bardstown, KY 40004, USA
    Pediatrics 118:2135-45. 2006
    ..We conducted a noninferiority immunogenicity study to bridge the efficacy findings in young women to preadolescent and adolescent girls and boys, who represent a primary target for human papillomavirus vaccination...
  28. ncbi Short-course antimicrobial therapy of streptococcal pharyngitis
    Stan L Block
    Kentucky Pediatric Research, Bardstown, Kentucky, USA
    Clin Pediatr (Phila) 42:663-71. 2003
    ..In light of recent reports regarding the high rate of failure with azithromycin and increasing macrolide resistance, clinicians should prescribe standard doses of this drug for 5 days with caution...